πŸ‡ΊπŸ‡Έ FDA
Patent

US 6806080

Hybrid vectors for gene therapy

expired A61KA61K48/00

Quick answer

US patent 6806080 (Hybrid vectors for gene therapy) held by The Regents of the University of California expires Mon Oct 14 2024 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Oct 19 2004 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 14 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
14
CPC classes
A61K, A61K48/00